CBD Life Sciences (OTCMKTS:CBDL) Stock In Focus: Company Introduces Delta-8 and Delta-9 Infused Gummies

August 19, 2022

CBD Life Sciences (OTCMKTS: CBDL), via its wholly owned subsidiary LBC Bioscience Inc., announced on August 18, 2022, about introducing a product that is infused with both Delta-8 & Delta-9. These yummy, apple-flavored gummies contain 15MG of Delta-8 & 10MG of Delta-9 per gummy and will come in a 15-Count Jar. Trading Data On Thursday, CBDL stock ended flat at $0.0002 with more than 78.84 million shares, compared to its…

Read More >>

CBD Life Sciences (OTCMKTS:CBDL) Announces New Product Launch: Stock Flat

February 11, 2022

While it is true that the CBD Life Sciences (OTCMKTS:CBDL) stock was trading in a range on Thursday, it should be noted that there was important news about the company yesterday and that is something that investors could look into. Trading Data On Thursday, CBDL stock ended flat at $0.0002 with more than 238.56 million shares, compared to its average volume of 173.57 million shares. The stock moved within a…

Read More >>